Interleukin 34: a new modulator of human and experimental inflammatory bowel disease.

@article{Zwicker2015Interleukin3A,
  title={Interleukin 34: a new modulator of human and experimental inflammatory bowel disease.},
  author={Stephanie Zwicker and Gisele Lago Martinez and Madeleen Bosma and Marco Gerling and Reuben Clark and Mirjam Majster and Jan S{\"o}derman and Sven Almer and Elisabeth A Bostr{\"o}m},
  journal={Clinical science},
  year={2015},
  volume={129 3},
  pages={281-90}
}
IBD (inflammatory bowel disease), where CD (Crohn's disease) and UC (ulcerative colitis) represent the two main forms, are chronic inflammatory conditions of the intestine. Macrophages play a central role in IBD pathogenesis and are regulated by major differentiation factors such as CSF-1 (colony-stimulating factor 1) in homoeostasis and inflammation. IL (interleukin)-34 has recently been discovered as a second ligand for CSF-1R (CSF-1 receptor). However, expression and involvement of IL-34 in… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Elevated serum and synovial fluid levels of interleukin-34 in rheumatoid arthritis: possible association with disease progression via interleukin-17 production.

Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research • 2013

Similar Papers

Loading similar papers…